Skip to main content
Erschienen in: Urolithiasis 4/2011

01.08.2011 | Invited Review

A hypothesis of calcium stone formation: an interpretation of stone research during the past decades

verfasst von: Hans-Göran Tiselius

Erschienen in: Urolithiasis | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

An interpretation of previous and recent observation on calcium salt crystallization and calcium stone formation provide the basis for formulation of a hypothetical series of events leading to calcium oxalate (CaOx) stone formation in the urinary tract. The various steps comprise a primary precipitation of calcium phosphate (CaP) at high nephron levels, establishment of large intratubular and/or interstitial (sub-epithelial) aggregates of CaP. These crystal masses subsequently might be dissolved during periods with low urine pH. On the denuded surface of subepithelial or intratubularly trapped CaP, release of calcium ions can result in very high ion-activity products of CaOx, particularly during simultaneous periods with peaks of CaOx supersaturation. Crystals of CaOx may result from nucleation in the macromolecular environment surrounding the apatite crystal phase. In the presence of low pH, low citrate and high ion-strength of urine, formation of large CaOx crystal masses can be accomplished by self-aggregation of Tamm–Horsfall mucoprotein. Following dislodgment of the initially fixed CaOx stone embryo, the further development into to clinically relevant stone is accomplished by CaOx crystal growth and CaOx crystal aggregation of the retained stone material. The latter process is modified by a number of inhibitors and promoters present in urine. The retention of the stone is a consequence of anatomical as well as hydrodynamic factors.
Literatur
1.
Zurück zum Zitat Tiselius HG (1996) Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 33–64 Tiselius HG (1996) Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 33–64
2.
Zurück zum Zitat Wendt-Nordahl G, Evan AP, Spahn M, Knoll T (2008) Calcium oxalate stone formation. New pathogenetic aspects of an old disease. Urologe A 47:540–544 Wendt-Nordahl G, Evan AP, Spahn M, Knoll T (2008) Calcium oxalate stone formation. New pathogenetic aspects of an old disease. Urologe A 47:540–544
3.
Zurück zum Zitat Hess B, Kok DJ (1996) Nucleation, growth and aggregation of stone-forming crystals. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 3–32 Hess B, Kok DJ (1996) Nucleation, growth and aggregation of stone-forming crystals. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 3–32
4.
Zurück zum Zitat Achilles W (1997) In vitro crystallization systems for the study of urinary stone formation. World J Urol 244–251 Achilles W (1997) In vitro crystallization systems for the study of urinary stone formation. World J Urol 244–251
5.
Zurück zum Zitat Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB (1978) Risk factors n calcium stone disease of the urinary tract. Br J Urol 50:449–454PubMedCrossRef Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB (1978) Risk factors n calcium stone disease of the urinary tract. Br J Urol 50:449–454PubMedCrossRef
6.
Zurück zum Zitat Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131–137CrossRef Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131–137CrossRef
7.
8.
Zurück zum Zitat Coe FL, Parks JH, Nakagawa Y (1991) Protein inhibitors of crystallization. Semin Urol 11:98–109 Coe FL, Parks JH, Nakagawa Y (1991) Protein inhibitors of crystallization. Semin Urol 11:98–109
9.
Zurück zum Zitat Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. III studies on the role of Tamm–Horsfall mucoprotein and ionic strength. J Urol 136:505–507PubMed Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. III studies on the role of Tamm–Horsfall mucoprotein and ionic strength. J Urol 136:505–507PubMed
10.
Zurück zum Zitat Roberston WG, Scurr DS, Bridge M (1981) Factors influencing the crystallisation of calcium oxalate—critique. J Cryst Growth 53:182–194CrossRef Roberston WG, Scurr DS, Bridge M (1981) Factors influencing the crystallisation of calcium oxalate—critique. J Cryst Growth 53:182–194CrossRef
11.
Zurück zum Zitat Lieske JC, Walsh-Reitz MM, Toback FG (1992) Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol (Renal Electrolyte Physiol) 262:F622–F630 Lieske JC, Walsh-Reitz MM, Toback FG (1992) Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol (Renal Electrolyte Physiol) 262:F622–F630
12.
Zurück zum Zitat Yuen J, Gohel M, Poon N, Shum D, Tam PA, Au DW (2010) The initial and subsequent inflammatory events during calcium oxalate lithiasis. Clin Chim Acta 411:15–16CrossRef Yuen J, Gohel M, Poon N, Shum D, Tam PA, Au DW (2010) The initial and subsequent inflammatory events during calcium oxalate lithiasis. Clin Chim Acta 411:15–16CrossRef
13.
Zurück zum Zitat Vervaet B, Vehulst A, De Broe M, D′Haese P (2010) The tubular epithelium in the initiation and course of intratubular nephrocalcinosis. Urol Res 38:249–256PubMedCrossRef Vervaet B, Vehulst A, De Broe M, D′Haese P (2010) The tubular epithelium in the initiation and course of intratubular nephrocalcinosis. Urol Res 38:249–256PubMedCrossRef
14.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL, Worcester EM (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111–119PubMedCrossRef Evan AP, Lingeman JE, Coe FL, Worcester EM (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111–119PubMedCrossRef
15.
Zurück zum Zitat Matlaga BR, Kim JCW, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE (2006) Endoscopic evidence of calculus attachment to Randal’s plaque. J Urol 175:1720–1724PubMedCrossRef Matlaga BR, Kim JCW, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE (2006) Endoscopic evidence of calculus attachment to Randal’s plaque. J Urol 175:1720–1724PubMedCrossRef
16.
Zurück zum Zitat Randall A (1940) Papillary pathology as a precursor of primary renal calculus. J Urol 44:580 Randall A (1940) Papillary pathology as a precursor of primary renal calculus. J Urol 44:580
17.
Zurück zum Zitat Smith LH, Werness PG (1983) Hydroxyapatite—the forgotten crystal in calcium urolithiasis. Trans Am Clin Chem Assoc 95:183–190 Smith LH, Werness PG (1983) Hydroxyapatite—the forgotten crystal in calcium urolithiasis. Trans Am Clin Chem Assoc 95:183–190
18.
Zurück zum Zitat Öhman S, Larsson L, Tiselius HG (1992) Clinical significance of phosphate in calcium oxalate renal stones. Ann Clin Biochem 29:59–63PubMed Öhman S, Larsson L, Tiselius HG (1992) Clinical significance of phosphate in calcium oxalate renal stones. Ann Clin Biochem 29:59–63PubMed
19.
Zurück zum Zitat Leusmann DB, Blanschke R, Schwandt W (1990) Results of 5035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol 24:205–210PubMedCrossRef Leusmann DB, Blanschke R, Schwandt W (1990) Results of 5035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol 24:205–210PubMedCrossRef
20.
Zurück zum Zitat Tiselius HG, Larsson L (1993) Calcium phosphate—an important crystal phase in patients with recurrent calcium stone formation? Urol Res 21:175–180PubMedCrossRef Tiselius HG, Larsson L (1993) Calcium phosphate—an important crystal phase in patients with recurrent calcium stone formation? Urol Res 21:175–180PubMedCrossRef
21.
Zurück zum Zitat Grases F, March JG, Conte A, Costa-Bautzá A (1993) New aspects on the composition, structure and origin of calcium oxalate monohydate calculi. Eur Urol 24:381–386PubMed Grases F, March JG, Conte A, Costa-Bautzá A (1993) New aspects on the composition, structure and origin of calcium oxalate monohydate calculi. Eur Urol 24:381–386PubMed
22.
Zurück zum Zitat Fernandez-Conde M, Alcover J, Barastegui C, Carretero P (1995) Calculi of papillary origin. Ann Urol (Paris) 29:351–354 Fernandez-Conde M, Alcover J, Barastegui C, Carretero P (1995) Calculi of papillary origin. Ann Urol (Paris) 29:351–354
23.
Zurück zum Zitat Prien EL Sr (1975) The riddle of Randall′s plaques. J Urol 114:500–507PubMed Prien EL Sr (1975) The riddle of Randall′s plaques. J Urol 114:500–507PubMed
24.
Zurück zum Zitat Miller NL, Evan AP, Lingeman JE (2007) Pathogenesis of renal calculi. Urol Clin North Am 34:295–313PubMedCrossRef Miller NL, Evan AP, Lingeman JE (2007) Pathogenesis of renal calculi. Urol Clin North Am 34:295–313PubMedCrossRef
25.
Zurück zum Zitat de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van’t Noordende JM, Schröder FH (1995) Etiology of calcium oxalate nephrolithiasis in rats. II. Scanning Microsc 9:124–125 de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van’t Noordende JM, Schröder FH (1995) Etiology of calcium oxalate nephrolithiasis in rats. II. Scanning Microsc 9:124–125
26.
Zurück zum Zitat Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831–841PubMedCrossRef Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831–841PubMedCrossRef
27.
Zurück zum Zitat Coe FL, Evan AP, Lingeman JE, Worcester EM (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239–247PubMedCrossRef Coe FL, Evan AP, Lingeman JE, Worcester EM (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239–247PubMedCrossRef
28.
Zurück zum Zitat Ahlstrand C, Tiselius HG, Larsson L (1984) Studies on crystalluria in calcium oxalate stone formers. Urol Res 12:103–106PubMedCrossRef Ahlstrand C, Tiselius HG, Larsson L (1984) Studies on crystalluria in calcium oxalate stone formers. Urol Res 12:103–106PubMedCrossRef
29.
Zurück zum Zitat Kok DJ (1996) Free and fixed particle mechanism, a review. Scanning Microsc 10:471–486PubMed Kok DJ (1996) Free and fixed particle mechanism, a review. Scanning Microsc 10:471–486PubMed
30.
Zurück zum Zitat Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854PubMedCrossRef Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854PubMedCrossRef
31.
Zurück zum Zitat Finlayson B, Reid F (1978) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442–448PubMed Finlayson B, Reid F (1978) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442–448PubMed
32.
Zurück zum Zitat Kok DJ, Khan SR (1995) Chances for free or fixed particle mechanism. In: Rao PN, Kavanagh JP, Tiselius HG (eds) Urolithiasis Consensus and Controversies. Lithtripter Unit, Withington Hospital, Manchester, pp 431–432 Kok DJ, Khan SR (1995) Chances for free or fixed particle mechanism. In: Rao PN, Kavanagh JP, Tiselius HG (eds) Urolithiasis Consensus and Controversies. Lithtripter Unit, Withington Hospital, Manchester, pp 431–432
33.
Zurück zum Zitat Crassweller PO, Brandes L, Katrizoglou A, Oreopoulos DG (1979) Studies on crystalluria in recurrent calcium lithiasis. Can J Surg 22:527–529PubMed Crassweller PO, Brandes L, Katrizoglou A, Oreopoulos DG (1979) Studies on crystalluria in recurrent calcium lithiasis. Can J Surg 22:527–529PubMed
34.
Zurück zum Zitat Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166–181CrossRef Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166–181CrossRef
35.
Zurück zum Zitat Adamthwaite DN (1983) Urinary particulate activity in urinary calculus disease. Br J Urol 55:95–99PubMedCrossRef Adamthwaite DN (1983) Urinary particulate activity in urinary calculus disease. Br J Urol 55:95–99PubMedCrossRef
36.
Zurück zum Zitat Asplin J, DeGanello S, Nakgawa YN, Coe F (1991) Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613 Asplin J, DeGanello S, Nakgawa YN, Coe F (1991) Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613
37.
Zurück zum Zitat Tiselius HG, Hojgaard I (1999) Some aspects of the intratubular precipitation of calcium salts. J Am Soc Nephrol 10:S373–S375 Tiselius HG, Hojgaard I (1999) Some aspects of the intratubular precipitation of calcium salts. J Am Soc Nephrol 10:S373–S375
38.
Zurück zum Zitat Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613PubMed Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613PubMed
39.
Zurück zum Zitat Luptak J, Bek-Jensen H, Fornander AM, Hojgaard I, Nilsson MA, Tiselius HG (1994) Crystallization of calcium oxalate and calcium phosphate at supersaturation levels corresponding to those in different parts of the nephron. Scanning Microsc 8:47–62 Luptak J, Bek-Jensen H, Fornander AM, Hojgaard I, Nilsson MA, Tiselius HG (1994) Crystallization of calcium oxalate and calcium phosphate at supersaturation levels corresponding to those in different parts of the nephron. Scanning Microsc 8:47–62
40.
Zurück zum Zitat Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1996) Crystallisation during volume reduction of solutions with an ion-composition corresponding to that in the distal tubuli. Scanning Microsc 10:487–498PubMed Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1996) Crystallisation during volume reduction of solutions with an ion-composition corresponding to that in the distal tubuli. Scanning Microsc 10:487–498PubMed
41.
Zurück zum Zitat Berg C, Tiselius HG (1986) The effect of pH on the risk of calcium oxalate crystallization in urine. Eur Urol 12:59–61PubMed Berg C, Tiselius HG (1986) The effect of pH on the risk of calcium oxalate crystallization in urine. Eur Urol 12:59–61PubMed
42.
Zurück zum Zitat Christoffersen MR, Christoffersen J, Kibalczyc W (1990) Apparent solubilities of two amorphous calcium phosphates and of octa calcium phosphate in the temperature range 30–42°C. J Cryst Growth 106:349–354CrossRef Christoffersen MR, Christoffersen J, Kibalczyc W (1990) Apparent solubilities of two amorphous calcium phosphates and of octa calcium phosphate in the temperature range 30–42°C. J Cryst Growth 106:349–354CrossRef
43.
Zurück zum Zitat DeGanello S, Asplin J, Coe FL (1990) Evidence that the fluid in the thin segment of the loop of Henle normally is supersaturated and forms poorly crystallized hydroxyapatite that can initiate renal stones. (Abstract). Kidney Int 37:472 DeGanello S, Asplin J, Coe FL (1990) Evidence that the fluid in the thin segment of the loop of Henle normally is supersaturated and forms poorly crystallized hydroxyapatite that can initiate renal stones. (Abstract). Kidney Int 37:472
44.
Zurück zum Zitat Koutsoukos PG, Nancollas GH (1981) Crystal growth of calcium phosphates—epitaxial considerations. J Cryst Growth 53:10–19CrossRef Koutsoukos PG, Nancollas GH (1981) Crystal growth of calcium phosphates—epitaxial considerations. J Cryst Growth 53:10–19CrossRef
45.
46.
Zurück zum Zitat Lundager-Madsen HE, Christensson F (1991) Precipitation of calcium phosphate at 40°C from neutral solution. J Cryst Growth 114:613–618CrossRef Lundager-Madsen HE, Christensson F (1991) Precipitation of calcium phosphate at 40°C from neutral solution. J Cryst Growth 114:613–618CrossRef
47.
Zurück zum Zitat Baumann JM, Ackermann D, Affolter B (1989) The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs. Urol Res 17:153–155PubMed Baumann JM, Ackermann D, Affolter B (1989) The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs. Urol Res 17:153–155PubMed
48.
Zurück zum Zitat Khori KMK, Ishikawa Y, Katayama Y, Takada M, Katoh Y, Kataoka K, Iguchi M, Kurita T (1991) Relationship between metabolic acidosis and calcium phosphate stone formation in women. Int Urol Nephrol 23:307–316CrossRef Khori KMK, Ishikawa Y, Katayama Y, Takada M, Katoh Y, Kataoka K, Iguchi M, Kurita T (1991) Relationship between metabolic acidosis and calcium phosphate stone formation in women. Int Urol Nephrol 23:307–316CrossRef
49.
Zurück zum Zitat Evan AP, Lingeman J, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaques of patients with nephrolithiasis begins in basement membranes of the loop of Henle. J Clin Invest 111:602–605 Evan AP, Lingeman J, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaques of patients with nephrolithiasis begins in basement membranes of the loop of Henle. J Clin Invest 111:602–605
50.
Zurück zum Zitat Sepe V, Adamo G, La Fianza A, Libetta C, Giuliano MG, Soccio G (2006) Henle loop basement membrane as initial site for Randall plaque formation. Am J Kidney Dis 48:706–711PubMedCrossRef Sepe V, Adamo G, La Fianza A, Libetta C, Giuliano MG, Soccio G (2006) Henle loop basement membrane as initial site for Randall plaque formation. Am J Kidney Dis 48:706–711PubMedCrossRef
51.
Zurück zum Zitat Tiselius HG (1996) Estimated levels of superstauration with calcium phosphate and calcium oxalate in the distal tubuli. Urol Res 25:153–159CrossRef Tiselius HG (1996) Estimated levels of superstauration with calcium phosphate and calcium oxalate in the distal tubuli. Urol Res 25:153–159CrossRef
52.
Zurück zum Zitat Tiselius HG, Hallin A, Lindbäck B (2001) Crystallisation properties in stone forming and normal subjects urine diluted using a standardized procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Urol Res 29:75–82PubMedCrossRef Tiselius HG, Hallin A, Lindbäck B (2001) Crystallisation properties in stone forming and normal subjects urine diluted using a standardized procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Urol Res 29:75–82PubMedCrossRef
53.
Zurück zum Zitat Kok DJ, Schell-Feith EA (1999) Risk factors for crystallisation in the nephron: the role of renal develpment. J Am Soc Nephrol 10:S364–S370PubMed Kok DJ, Schell-Feith EA (1999) Risk factors for crystallisation in the nephron: the role of renal develpment. J Am Soc Nephrol 10:S364–S370PubMed
54.
Zurück zum Zitat Hering F, Lueoend G, Briellmann T, Seiler H, Guggenheim H, Rutishauser G (1988) Stone formation in the human kidney. In: Walker VR, Sutton RL, Cameron B, Pak CYC, Roberston WG (eds) Urolithiasis. Plenum Press, New York, pp 73–74 Hering F, Lueoend G, Briellmann T, Seiler H, Guggenheim H, Rutishauser G (1988) Stone formation in the human kidney. In: Walker VR, Sutton RL, Cameron B, Pak CYC, Roberston WG (eds) Urolithiasis. Plenum Press, New York, pp 73–74
55.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM (2009) Intratubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76:1081–1088PubMedCrossRef Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM (2009) Intratubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76:1081–1088PubMedCrossRef
56.
Zurück zum Zitat Resnick MI, Boyce WH (1978) Sperical calcium bodies in stone-forming urine. Invest Urol 15:449–451PubMed Resnick MI, Boyce WH (1978) Sperical calcium bodies in stone-forming urine. Invest Urol 15:449–451PubMed
57.
Zurück zum Zitat Achilles W, Jockel U, Schaper A, Ulshofer B, Riedmiller H (1994) Formation of urinary stones in vitro: growth of calcium oxalate on spherulites of calcium phosphate in gel. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis, vol 2. Plenum Press, New York, pp 161–165 Achilles W, Jockel U, Schaper A, Ulshofer B, Riedmiller H (1994) Formation of urinary stones in vitro: growth of calcium oxalate on spherulites of calcium phosphate in gel. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis, vol 2. Plenum Press, New York, pp 161–165
58.
Zurück zum Zitat Fan J, Chandoke PS (1999) Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique. J Urol 161:1685–1688PubMedCrossRef Fan J, Chandoke PS (1999) Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique. J Urol 161:1685–1688PubMedCrossRef
59.
Zurück zum Zitat Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A (1995) Effect of urinary acromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta 239:1–11PubMedCrossRef Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A (1995) Effect of urinary acromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta 239:1–11PubMedCrossRef
60.
Zurück zum Zitat Carvalho M, Mulinari R, Nakagawa Y (2002) Role of Tamm–Horsfall protein and uromodulin in calcium oxalate crystallization. Br J Med Biol Res 35:1165–1172CrossRef Carvalho M, Mulinari R, Nakagawa Y (2002) Role of Tamm–Horsfall protein and uromodulin in calcium oxalate crystallization. Br J Med Biol Res 35:1165–1172CrossRef
61.
Zurück zum Zitat Maslamani S, Glenton PA, Khan SR (2000) Changes in urine macromolecular composition during processing. J Urol 164:230–236PubMedCrossRef Maslamani S, Glenton PA, Khan SR (2000) Changes in urine macromolecular composition during processing. J Urol 164:230–236PubMedCrossRef
62.
Zurück zum Zitat Gorski JP (1992) Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calif Tissue Int 50:391–396CrossRef Gorski JP (1992) Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calif Tissue Int 50:391–396CrossRef
63.
Zurück zum Zitat Fasano JM, Khan S (2001) Intratubular crystallisation of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59:169–178PubMedCrossRef Fasano JM, Khan S (2001) Intratubular crystallisation of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59:169–178PubMedCrossRef
64.
Zurück zum Zitat Talham DR, Backov R, Benitez IO, Sharbaugh DM, Whipps S, Khan SR (2006) Role of lipids in urinary stones: studies of calcium oxalate precipitation at phospholipid langmuir monolayers. Langmuir 22:2450–2456PubMedCrossRef Talham DR, Backov R, Benitez IO, Sharbaugh DM, Whipps S, Khan SR (2006) Role of lipids in urinary stones: studies of calcium oxalate precipitation at phospholipid langmuir monolayers. Langmuir 22:2450–2456PubMedCrossRef
65.
Zurück zum Zitat Wuthier RE (1973) The role of phospholipids in biological calcification: Distribution of phospholipase activity in calcifying epiphyseal cartilage. Clin Orthoped Relat Res 90:191–200 Wuthier RE (1973) The role of phospholipids in biological calcification: Distribution of phospholipase activity in calcifying epiphyseal cartilage. Clin Orthoped Relat Res 90:191–200
66.
Zurück zum Zitat Wang L, Guan X, Tang R, Hoyer J, Wierzbicki A, De Yorero J, Nancollas G (2008) Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J Phys Chem B 112:9151–9157PubMedCrossRef Wang L, Guan X, Tang R, Hoyer J, Wierzbicki A, De Yorero J, Nancollas G (2008) Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J Phys Chem B 112:9151–9157PubMedCrossRef
67.
Zurück zum Zitat Gebauer D, Völkel A, Cölfen H (2008) Stable prenucleation calcium carbonate clusters. Science 322:1819–1822PubMedCrossRef Gebauer D, Völkel A, Cölfen H (2008) Stable prenucleation calcium carbonate clusters. Science 322:1819–1822PubMedCrossRef
68.
Zurück zum Zitat Bauman JM, Affolter B, Caprez U, Henze U, Lauper D, Maier F (2001) Hydroxyapatite induction and secondary aggregation, two important processes in calcium stone formation. Urol Res 29:417–422CrossRef Bauman JM, Affolter B, Caprez U, Henze U, Lauper D, Maier F (2001) Hydroxyapatite induction and secondary aggregation, two important processes in calcium stone formation. Urol Res 29:417–422CrossRef
69.
Zurück zum Zitat Nakagawa Y, Ahmed MA, Hall SL, Deganello S, Coe FL (1987) Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal gowth. J Clin Invest 79:1782–1787PubMedCrossRef Nakagawa Y, Ahmed MA, Hall SL, Deganello S, Coe FL (1987) Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal gowth. J Clin Invest 79:1782–1787PubMedCrossRef
70.
Zurück zum Zitat Coe FL, Nakagawa Y, Parks JH (1991) Inhibitors within the nephron. Am J Kidney Dis 17:407–413PubMed Coe FL, Nakagawa Y, Parks JH (1991) Inhibitors within the nephron. Am J Kidney Dis 17:407–413PubMed
71.
Zurück zum Zitat Ryall RL, Harnett RM, Hibbers CM, Edyvane KA, Marshall VR (1991) Effects of chondroitin sulphate, human serum albumin and Tamm–Horsfall mucoprotein on calcium oxalate crystallizaion in undiluted human urine. Urol Res 19:181–188PubMedCrossRef Ryall RL, Harnett RM, Hibbers CM, Edyvane KA, Marshall VR (1991) Effects of chondroitin sulphate, human serum albumin and Tamm–Horsfall mucoprotein on calcium oxalate crystallizaion in undiluted human urine. Urol Res 19:181–188PubMedCrossRef
72.
Zurück zum Zitat Khan SR (1995) Experimental calcium oxalate nephrolithiasis and the formation human urinary stones. Scanning Microsc 9:89–100PubMed Khan SR (1995) Experimental calcium oxalate nephrolithiasis and the formation human urinary stones. Scanning Microsc 9:89–100PubMed
73.
Zurück zum Zitat Khan SR, Hackett RL (1991) Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:711–712 Khan SR, Hackett RL (1991) Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:711–712
74.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in the basement membranes of the thin loops of Henle. J Clin Invest 111:607–616PubMed Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in the basement membranes of the thin loops of Henle. J Clin Invest 111:607–616PubMed
75.
Zurück zum Zitat Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stones formation. Urol Res 38:147–160PubMedCrossRef Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stones formation. Urol Res 38:147–160PubMedCrossRef
76.
Zurück zum Zitat Pak CYC (1981) Potential etiologic role of brushite in the formation of calcium (renal) stones. J Cryst Growth 53:202–208CrossRef Pak CYC (1981) Potential etiologic role of brushite in the formation of calcium (renal) stones. J Cryst Growth 53:202–208CrossRef
77.
Zurück zum Zitat Matlaga BR, Coe FL, Evans APELJ (2007) The role of Randall’s plaque in the pathogenesis of calcium stones. J Urol 177:31–38PubMedCrossRef Matlaga BR, Coe FL, Evans APELJ (2007) The role of Randall’s plaque in the pathogenesis of calcium stones. J Urol 177:31–38PubMedCrossRef
78.
Zurück zum Zitat Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323CrossRef Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323CrossRef
79.
Zurück zum Zitat Evan AP, Lingeman J, Coe FL, Worcester E (2006) Randall’s plaque: pathogenesis and role in calcium calcium oxalate nephrolithiasis. Kidney Int 69:1313–1318PubMedCrossRef Evan AP, Lingeman J, Coe FL, Worcester E (2006) Randall’s plaque: pathogenesis and role in calcium calcium oxalate nephrolithiasis. Kidney Int 69:1313–1318PubMedCrossRef
80.
Zurück zum Zitat Kleinman J, Alatalo L, Beshensky A, AE J (2008) Acidic polyanion poly(acrylic acid) prevents calcium oxalate deposition. Kidney Int 74:919–924PubMedCrossRef Kleinman J, Alatalo L, Beshensky A, AE J (2008) Acidic polyanion poly(acrylic acid) prevents calcium oxalate deposition. Kidney Int 74:919–924PubMedCrossRef
81.
82.
Zurück zum Zitat Sutor DJ, Percival JM, Piper KAJ (1979) Urinary inhibitors of calcium phosphate formation: the inhibitory activity in artificial urines. Br J Urol 51:1–5PubMedCrossRef Sutor DJ, Percival JM, Piper KAJ (1979) Urinary inhibitors of calcium phosphate formation: the inhibitory activity in artificial urines. Br J Urol 51:1–5PubMedCrossRef
83.
Zurück zum Zitat Györy AZ, Ashby R (1999) Calcium salt urolithiasis. Review of theory for diagnosis and management. Clin Nephrol 51:197–208PubMed Györy AZ, Ashby R (1999) Calcium salt urolithiasis. Review of theory for diagnosis and management. Clin Nephrol 51:197–208PubMed
84.
Zurück zum Zitat Kok D, Papapoulos SE, Blomen LJMJ, Bijvoet OLM (1988) Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int 34:346–350PubMedCrossRef Kok D, Papapoulos SE, Blomen LJMJ, Bijvoet OLM (1988) Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int 34:346–350PubMedCrossRef
85.
Zurück zum Zitat Kok D, Papapoulos SE, Bijvoet OLM (1986) Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1056–1058 Kok D, Papapoulos SE, Bijvoet OLM (1986) Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1056–1058
86.
Zurück zum Zitat Tiselius HG (1984) Urinary pH and calcium oxalate crystallization. In: Fortschritte der Urolige und Nephrologie. Pathogenese und Klinik der Harnsteinae X. (eds Vahlensieck W, Gasser, G). Steinkopff, Darmstadt 22:184–187 Tiselius HG (1984) Urinary pH and calcium oxalate crystallization. In: Fortschritte der Urolige und Nephrologie. Pathogenese und Klinik der Harnsteinae X. (eds Vahlensieck W, Gasser, G). Steinkopff, Darmstadt 22:184–187
87.
Zurück zum Zitat Moreno EC, Varughese K (1981) Crystal growth of calcium apatites from dilute solutions. J Cryst Growth 53:20–30CrossRef Moreno EC, Varughese K (1981) Crystal growth of calcium apatites from dilute solutions. J Cryst Growth 53:20–30CrossRef
88.
Zurück zum Zitat Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. II Inhibition by natural crystal growth inhibitors. Invest Urol 13:36–39PubMed Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. II Inhibition by natural crystal growth inhibitors. Invest Urol 13:36–39PubMed
89.
Zurück zum Zitat Morse RM, Resnick MI (1988) A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139:869–873PubMed Morse RM, Resnick MI (1988) A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139:869–873PubMed
90.
Zurück zum Zitat Curreri PA, Onoda G, Finlayson B (1981) A comparative appraisal of adsorption of citrate on whewellite seed crystals. J Cryst Growth 53:209–214CrossRef Curreri PA, Onoda G, Finlayson B (1981) A comparative appraisal of adsorption of citrate on whewellite seed crystals. J Cryst Growth 53:209–214CrossRef
91.
Zurück zum Zitat Robertson WG, Peacock M, Marshall RW, Marshall DHCNBE (1976) Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. New Engl J Med 294:249–252PubMedCrossRef Robertson WG, Peacock M, Marshall RW, Marshall DHCNBE (1976) Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. New Engl J Med 294:249–252PubMedCrossRef
92.
Zurück zum Zitat Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201–207PubMedCrossRef Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201–207PubMedCrossRef
93.
Zurück zum Zitat Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1998) The influence of hydroxyapatite seed on the crystallisation induced by volume reduction of solutions with an ion composition corresponding to that in the distal tubule at different pH levels. Scand J Urol Nephrol 32:311–319PubMedCrossRef Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1998) The influence of hydroxyapatite seed on the crystallisation induced by volume reduction of solutions with an ion composition corresponding to that in the distal tubule at different pH levels. Scand J Urol Nephrol 32:311–319PubMedCrossRef
94.
Zurück zum Zitat Mandel N, Mandel G (1990) Epitaxis in renal stones. In: Wickham JA, Buck AC (eds) Renal tract stone. Churchill Livingstone, London, pp 87–101 Mandel N, Mandel G (1990) Epitaxis in renal stones. In: Wickham JA, Buck AC (eds) Renal tract stone. Churchill Livingstone, London, pp 87–101
95.
Zurück zum Zitat Khan SR, Glenton PA (2010) Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 184:1189–1196PubMedCrossRef Khan SR, Glenton PA (2010) Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 184:1189–1196PubMedCrossRef
96.
Zurück zum Zitat Embery G, Rees S, Hall R, Rose K, Waddington R, Shellis P (1998) Calcium- and apatite-binding properties of glucuronic acid-rich and iduronic acid-rich glycosmanoglycans and proteoglycans. Eur J Oral Sci 106(suppl 1):267–273PubMed Embery G, Rees S, Hall R, Rose K, Waddington R, Shellis P (1998) Calcium- and apatite-binding properties of glucuronic acid-rich and iduronic acid-rich glycosmanoglycans and proteoglycans. Eur J Oral Sci 106(suppl 1):267–273PubMed
97.
Zurück zum Zitat Hess B (1994) Tamm–Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393–398PubMed Hess B (1994) Tamm–Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393–398PubMed
98.
Zurück zum Zitat Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A (1991) Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine 70:345–359PubMedCrossRef Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A (1991) Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine 70:345–359PubMedCrossRef
99.
Zurück zum Zitat Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL (2008) Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured cells. Am J Physiol Renal Physiol 294:F355–F361PubMedCrossRef Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL (2008) Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured cells. Am J Physiol Renal Physiol 294:F355–F361PubMedCrossRef
100.
Zurück zum Zitat Tiselius HG, Lindbäck B, Fornander AM, Nilsson MA (2009) Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation. Urol Res 37:181–192PubMedCrossRef Tiselius HG, Lindbäck B, Fornander AM, Nilsson MA (2009) Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation. Urol Res 37:181–192PubMedCrossRef
101.
Zurück zum Zitat Leal JJ, Finlayson B (1977) Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces. Invest Urol 14:278–283PubMed Leal JJ, Finlayson B (1977) Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces. Invest Urol 14:278–283PubMed
102.
Zurück zum Zitat Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R (1979) The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 57:285–288PubMed Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R (1979) The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 57:285–288PubMed
103.
Zurück zum Zitat Langley SEM, Fry CH (1997) The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects. Br J Urol 79:8–14PubMed Langley SEM, Fry CH (1997) The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects. Br J Urol 79:8–14PubMed
104.
Zurück zum Zitat Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MAS (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151:571–574PubMed Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MAS (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151:571–574PubMed
105.
Zurück zum Zitat Elliot JS, Sharp R, Lewis L (1959) Urinary pH. J Urol 81:339–343 Elliot JS, Sharp R, Lewis L (1959) Urinary pH. J Urol 81:339–343
106.
107.
Zurück zum Zitat Wu W, Gerard D, Nancollas G (1999) Nucleation at surfaces: the importance of interfacial energy. J Am Soc Nephro 10(suppl 14):S355–S358 Wu W, Gerard D, Nancollas G (1999) Nucleation at surfaces: the importance of interfacial energy. J Am Soc Nephro 10(suppl 14):S355–S358
108.
Zurück zum Zitat Ahlstrand C, Tiselius HG (1987) Urine composition and stone formation during treatment with acetazolamide. Scand J Urol Nephrol 21:225–228PubMedCrossRef Ahlstrand C, Tiselius HG (1987) Urine composition and stone formation during treatment with acetazolamide. Scand J Urol Nephrol 21:225–228PubMedCrossRef
109.
Zurück zum Zitat Höjgaard I, Fornander AM, Nilsson MA, Tiselius HG (1999) Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: influence of hydroxyapatite seed crystals an urinary macromolecules. Urol Res 27:417–425PubMedCrossRef Höjgaard I, Fornander AM, Nilsson MA, Tiselius HG (1999) Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: influence of hydroxyapatite seed crystals an urinary macromolecules. Urol Res 27:417–425PubMedCrossRef
110.
Zurück zum Zitat Landis W, Silver F (2009) Mineral deposition in the extracellular matrices of vertebrate tissues: identification of possible apatite nucleation sites on type I collagen. Cells Tissues Organs 189:20–24PubMedCrossRef Landis W, Silver F (2009) Mineral deposition in the extracellular matrices of vertebrate tissues: identification of possible apatite nucleation sites on type I collagen. Cells Tissues Organs 189:20–24PubMedCrossRef
111.
Zurück zum Zitat Atmani F, Opalko FJ, Khan SR (1996) Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine. Urol Res 24:45–50PubMedCrossRef Atmani F, Opalko FJ, Khan SR (1996) Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine. Urol Res 24:45–50PubMedCrossRef
112.
Zurück zum Zitat Gul A, Res P (2007) Models for protein binding to calcium oxalate surfaces. Urol Res 35:63–71PubMedCrossRef Gul A, Res P (2007) Models for protein binding to calcium oxalate surfaces. Urol Res 35:63–71PubMedCrossRef
113.
Zurück zum Zitat Tiselius HG (1999) Factors influencing the course of calcium oxalate stone disease. Eur Urol 36:363–370PubMedCrossRef Tiselius HG (1999) Factors influencing the course of calcium oxalate stone disease. Eur Urol 36:363–370PubMedCrossRef
114.
Zurück zum Zitat Tiselius HG, Bek-Jensen H, Fornander AM, Nilsson MA (1995) Crystallisation properties in urine from calcium oxalate stone formers. J Urol 154:940–946PubMedCrossRef Tiselius HG, Bek-Jensen H, Fornander AM, Nilsson MA (1995) Crystallisation properties in urine from calcium oxalate stone formers. J Urol 154:940–946PubMedCrossRef
115.
Zurück zum Zitat Tiselius HG (1991) Aspects on the risk of calcium oxalate crystallisation in urine. Urol Int 47:255–259PubMedCrossRef Tiselius HG (1991) Aspects on the risk of calcium oxalate crystallisation in urine. Urol Int 47:255–259PubMedCrossRef
116.
Zurück zum Zitat Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131–137CrossRef Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131–137CrossRef
117.
Zurück zum Zitat Berg C, Tiselius HG (1989) The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals. Urol Res 17:167–172PubMedCrossRef Berg C, Tiselius HG (1989) The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals. Urol Res 17:167–172PubMedCrossRef
118.
Zurück zum Zitat Tiselius HG (2004) Recurrence prevention in patients with urinary tract stone disease. Scientific World Journal 31:417–425 Tiselius HG (2004) Recurrence prevention in patients with urinary tract stone disease. Scientific World Journal 31:417–425
119.
Zurück zum Zitat Caudarella R, Vescini F (2009) Urinary citrate and renal stone disease: the preventive role of alkali treatment. Arch Ital Urol Androl 81:182–187PubMed Caudarella R, Vescini F (2009) Urinary citrate and renal stone disease: the preventive role of alkali treatment. Arch Ital Urol Androl 81:182–187PubMed
120.
Zurück zum Zitat Cannon AB, Westropp JL, Ruby AL, Kass PH (2007) Evaluation of trends in urolith composition in cats: 5, 230 cases (1985–2004). J Am Vet Med Assoc 15:570–576CrossRef Cannon AB, Westropp JL, Ruby AL, Kass PH (2007) Evaluation of trends in urolith composition in cats: 5, 230 cases (1985–2004). J Am Vet Med Assoc 15:570–576CrossRef
Metadaten
Titel
A hypothesis of calcium stone formation: an interpretation of stone research during the past decades
verfasst von
Hans-Göran Tiselius
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 4/2011
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0349-3

Weitere Artikel der Ausgabe 4/2011

Urolithiasis 4/2011 Zur Ausgabe

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.